You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 123 No. 3, March 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Sciences
 This Article
 •Full text
 •PDF
 •Correction
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (17)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Transplantation, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Early Results of Penetrating Keratoplasty After Cultivated Limbal Epithelium Transplantation

Virender S. Sangwan, MS; Himanshu P. Matalia, MS; Geeta K. Vemuganti, MD; Ghazala Ifthekar, MSc; Anees Fatima, MSc; Shashi Singh, PhD; Gullapalli N. Rao, MD

Arch Ophthalmol. 2005;123:334-340.

Objective  To describe the early results of penetrating keratoplasty (PKP) in patients who had previously undergone cultivated limbal epithelium transplantation.

Methods  Medical records of patients with limbal stem cell deficiency due to chemical burns who underwent PKP after cultivated limbal epithelium transplantation were reviewed for demographics, primary etiology, type of limbal transplantation, ocular surface stability, visual acuity, graft clarity, and complications. Histopathologic features of the recipient corneal buttons were studied with special attention to epithelial status.

Results  Of the 125 patients with limbal stem cell deficiency treated with cultivated limbal epithelium transplantation, 15 underwent PKP at a mean interval of 7 months (range, 2-12 months) following cultivated limbal epithelium transplantation (autologous, n = 11; allogenic, n = 4). All 4 patients treated with allogenic cultivated limbal epithelium transplantation were undergoing immunosuppressive therapy. Fourteen (93%) of the 15 eyes had a successful corneal graft with a stable corneal epithelium. Preoperative best-corrected visual acuity was less than 20/200 in 14 of the 15 eyes. At a mean ± SD follow-up of 8.3 ± 5.0 months after PKP, the best-corrected visual acuity was more than 20/60 in 8 eyes, 20/200 to 20/60 in 5 eyes, and less than 20/200 in 2 eyes. Three of the 15 eyes experienced corneal allograft rejection, which was managed successfully. One eye with graft rejection also had glaucoma. None of the limbal epithelial allografts showed signs of rejection.

Conclusions  Early results of PKP following cultivated limbal epithelium transplantation are favorable when performed after stabilizing the ocular surface. Adequate immunosuppression is essential for allogenic cultivated limbal epithelium transplantation to avoid rejection. Corneal allografts can separately reject the limbal allografts.


Author Affiliations: Sudhakar and Sreekanth Ravi Stem Cell Biology Laboratory (Drs Sangwan, Matalia, and Vemuganti and Mss Ifthekar and Fatima), Cornea and Anterior Segment Service (Drs Sangwan and Rao), and Ophthalmic Pathology Laboratory (Dr Vemuganti), L V Prasad Eye Institute, and Center for Cellular and Molecular Biology (Dr Singh), Hyderabad, India.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Phenotypic Study After Cultivated Limbal Epithelial Transplantation for Limbal Stem Cell Deficiency
Kawashima et al.
Arch Ophthalmol 2007;125:1337-1344.
ABSTRACT | FULL TEXT  

Inherent Risks Associated With Manufacture of Bioengineered Ocular Surface Tissue
Schwab et al.
Arch Ophthalmol 2006;124:1734-1740.
ABSTRACT | FULL TEXT  

Autologous serum-derived cultivated oral epithelial transplants for severe ocular surface disease.
Ang et al.
Arch Ophthalmol 2006;124:1543-1551.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.